Fertility Limiting Diseases of Pelvic Organs and Their Influence on Receptivity of Endometrial Cavity: Prospective Clinical Trial
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · May 18, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain conditions that affect women's reproductive organs, such as adenomyosis, fibroids, and endometriosis, might influence the ability of the uterus to support a pregnancy. The main goal is to understand the differences in the lining of the uterus (called the endometrium) in women experiencing infertility due to these conditions compared to women with mild endometriosis or those who are healthy but facing infertility due to male factors. Researchers hope that by understanding these effects better, they can improve treatment options for women struggling with infertility related to these conditions.
To participate in this study, women aged 18 to 45 who have been trying to conceive for at least a year can join. It's important that participants agree to be part of the study. Women with adenomyosis, fibroids, or endometriosis will be compared to others with different conditions. If you join, you can expect to undergo assessments to help researchers gather valuable information about these fertility-limiting diseases. This study is currently recruiting participants, and the findings may lead to better fertility treatments in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • agreement with participation in the study
- • age between 18 - 45 years (at the start of patient´s participation in the study)women with at least 1 year infertility
- Exclusion Criteria:
- • -
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Prague, , Czechia
Patients applied
Trial Officials
Michal Mara
Principal Investigator
General Hospital in Prague
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported